This document discusses the risks of transmitting herpes simplex virus (HSV) from mother to neonate during delivery. There is a 40% risk of transmission with primary HSV infections. Neonatal herpes can cause severe neurological impairment or death. Factors like viral type, maternal antibodies, delivery mode, and rupture of membranes affect transmission risk. For primary infections in the 1st/2nd trimester, same-day referral for testing and acyclovir treatment is recommended, while caesarean is recommended for infections within 6 weeks of the due date. Recurrent infections pose a smaller 3% risk due to maternal antibodies, so antiviral treatment is usually unnecessary for delivery.